Credit Suisse Downgrades AZN To Underperform

Symbols: AZN
Share

Analysts at Credit Suisse downgrade AstraZeneca plc (NYSE: AZN) from "neutral" to "underperform."

AZN's shares lost 1.08% to close at $47.71 yesterday.

More Analyst Ratings here


 
 
< Previous
Merriman Curhan Ford Downgrades RGC To Neutral
Next >
Wells Fargo Securities Downgrades NBR To Market Perform
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust